| bacteria for the treatment of disorders |
2023-6-06 |
2023-9-05 |
|
| Bacteria engineered to reduce hyperphenylalaninemia |
2023-3-10 |
2023-6-20 |
|
| Bacteria engineered to reduce hyperphenylalaninemia |
2023-3-10 |
2023-6-20 |
|
| Bacteria for the treatment of disorders |
2023-3-01 |
2023-4-06 |
|
| Bacteria engineered to treat diseases that benefit from reduced gut … |
2022-11-23 |
2023-1-05 |
|
| Methods for reducing hyperphenylalaninemia |
2022-9-19 |
2023-3-23 |
|
| Engineered phenylalanine ammonia lyase enzymes |
2022-9-08 |
2023-3-16 |
|
| Recombinant cells for treating diseases associated with uric acid and methods … |
2022-9-01 |
2023-3-09 |
|
| Bacteria engineered to treat disorders involving the catabolism of a branched … |
2022-8-31 |
2022-9-22 |
|
| Recombinant bacteria engineered to treat diseases associated with methionine … |
2022-8-11 |
2023-4-06 |
|
| Microorganisms programmed to produce immune modulators and anti-cancer … |
2022-8-02 |
2023-7-20 |
|
| Bacteria engineered to treat disorders in which oxalate is detrimental |
2022-7-12 |
2022-9-01 |
|
| Bacteria engineered to treat diseases that benefit from reduced gut … |
2022-6-08 |
2023-2-09 |
|
| Microorganisms engineered to reduce hyperphenylalaninemia |
2022-6-03 |
2022-11-17 |
|
| Bacteria engineered to secrete active proteins |
2022-4-12 |
2022-10-20 |
|
| Bacteria engineered to treat disorders in which oxalate is detrimental |
2022-3-24 |
2022-9-29 |
|
| Bacteria engineered to treat disorders in which oxalate is detrimental |
2022-2-02 |
2022-7-28 |
|
| Bacteria engineered to treat metabolic diseases |
2022-1-26 |
2022-7-21 |
|
| Methods of treating cancer using recombinant microorganisms expressing a sting … |
2022-1-11 |
2022-7-14 |
|
| Biosynthesis of enzymes for use in treatment of maple syrup urine disease (msud … |
2021-12-19 |
2022-2-01 |
|
| Microorganisms engineered to reduce hyperphenylalaninemia |
2021-12-17 |
2022-7-07 |
|
| Bacteria engineered to treat disorders involving the catabolism of a branched … |
2021-12-10 |
2022-6-02 |
|
| Engineered microorganisms |
2021-12-02 |
2022-7-07 |
|
| Bacteria engineered to secrete active proteins |
2021-9-30 |
2022-4-07 |
|
| Recombinant bacteria for production of d-lactate and/or l-lactate and uses … |
2021-8-06 |
2022-2-10 |
|
| Recombinant bacteria for production of indole-3-acetic acid (iaa) and uses … |
2021-5-26 |
2021-12-02 |
|
| Surface display of proteins on recombinant bacteria and uses thereof |
2021-5-26 |
2021-12-02 |
|
| Recombinant bacteria for use as a vaccine to prevent covid19 infection |
2021-4-07 |
2023-6-15 |
|
| Bacteria engineered to treat disorders involving the catabolism of leucine |
2021-3-17 |
2021-9-23 |
|
| Recombinant bacteria engineered to treat diseases associated with uric acid and … |
2021-2-25 |
2021-9-02 |
|
| Recombinant bacteria engineered to treat diseases associated with methionine … |
2021-2-12 |
2022-12-21 |
|
| Optimized bacteria engineered to treat disorders involving the catabolism of … |
2021-1-14 |
2021-7-22 |
|
| Engineered bacteria for treating diseases associated with hyperammonemia |
2020-12-25 |
2021-4-22 |
|
| Bacteria engineered to treat diseases associated with hyperammonemia |
2020-12-16 |
2021-6-17 |
|
| Bacteria engineered to treat diseases associated with hyperammonemia |
2020-10-19 |
2020-11-30 |
|
| Synergistic combinations of arginine-producing bacteria and/or ammonia- … |
2020-5-13 |
2020-11-19 |
|
| Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut … |
2020-5-01 |
2021-4-01 |
|
| Genetically engineered microorganisms |
2020-4-29 |
2022-6-29 |
|
| Microorganisms programmed to produce immune modulators and anti-cancer … |
2019-11-25 |
2020-1-30 |
|
| Combination therapies of microorganisms and immune modulators for use in … |
2019-11-08 |
2020-5-14 |
|
| Bacteria engineered to treat liver disease |
2019-5-31 |
2020-10-15 |
|
| Engineered bacteria expressing racemase for treating diseases associated with … |
2018-11-02 |
2019-5-09 |
|
| Bacteria engineered to treat nonalcoholic steatohepatitis (nash) |
2017-2-10 |
2017-8-17 |
|
| Bacteria engineered to treat diseases associated with hyperammonemia |
2017-2-10 |
2017-10-19 |
|
| Bacteria engineered to treat diseases that benefit from reduced gut … |
2017-2-03 |
2021-6-03 |
|
| Bacteria engineered to treat diseases that benefit from reduced gut … |
2017-2-03 |
2017-9-28 |
|
| Bacteria engineered to treat diseases associated with tryptophan metabolism |
2017-2-03 |
2017-8-10 |
|
| Bacteria engineered to treat disorders associated with bile salts |
2017-1-11 |
2017-7-20 |
|
| Bacteria engineered to detoxify deleterious molecules |
2017-1-11 |
2017-9-28 |
|
| Recombinant bacteria engineered to treat diseases and disorders associated with … |
2017-1-11 |
2017-7-20 |
|
| Recombinant bacteria engineered to treat diseases and disorders associated with … |
2017-1-11 |
2019-9-19 |
|
| Microorganisms programmed to produce immune modulators and anti-cancer … |
2017-1-11 |
2018-11-21 |
|
| Bacteria engineered to treat disorders involving propionate catabolism |
2017-1-09 |
2017-8-03 |
|
| Bacteria engineered to treat metabolic diseases |
2016-12-28 |
2019-1-10 |
|
| Bacteria engineered to treat metabolic diseases |
2016-12-28 |
2018-11-21 |
|
| Bacteria engineered to treat disorders in which trimethylamine (tma) is … |
2016-10-28 |
2017-5-04 |
|
| Combination cancer treatments utilizing synthetic oligonucleotides and egfr-tki … |
2016-10-20 |
2017-2-09 |
|
| Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut … |
2016-9-08 |
2018-11-01 |
|
| Bacteria engineered to treat disorders involving propionate catabolism |
2016-7-29 |
2018-2-22 |
|
| Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and … |
2016-6-24 |
2017-2-09 |
|
| Multi-layered control of gene expression in genetically engineered bacteria |
2016-6-24 |
2017-2-09 |
|
| Bacteria engineered to treat metabolic diseases |
2016-6-24 |
2018-5-02 |
|
| Bacteria engineered to treat a disease or disorder |
2016-5-13 |
2018-3-21 |
|
| Bacteria engineered to treat a disease or disorder |
2016-5-13 |
2017-2-23 |
|
| Compositions and methods related to mirna modulation of neovascularization or … |
2016-4-19 |
2016-8-04 |
|
| GENETICALLY MODIFIED BACTERIA, PHARMACEUTICALLY ACCEPTABLE COMPOSITION … |
2016-3-02 |
2021-11-30 |
|
| SYNTHETIC MIMICS OF miR-34 |
2016-2-19 |
2016-8-25 |
|
| Probiotic organisms for diagnosis, monitoring, and treatment of inflammatory … |
2015-12-22 |
2016-6-30 |
|
| Bacteria engineered to treat diseases associated with hyperammonemia |
2015-12-04 |
2022-1-19 |
|
| Combination cancer therapy with c-met inhibitors and synthetic oligonucleotides |
2015-11-19 |
2016-6-02 |
|
| Synthetic mimics of mir-124 |
2015-11-11 |
2016-3-03 |
|
| Combination cancer treatments utilizing micrornas and egfr-tki inhibitors |
2015-6-10 |
2015-10-01 |
|
| Methods and compositions involving mirna and mirna inhibitor molecules |
2015-5-14 |
2015-12-03 |
|
| Microrna dosing regimens |
2015-4-01 |
2017-2-08 |
|
| Sorafenib-microrna combination therapy for liver cancer |
2015-2-27 |
2015-9-03 |
|
| Biomarkers of miR-34 activity |
2014-6-24 |
2015-12-17 |
|
| Methods and Compositions Involving miRNAs In Cancer Stem Cells |
2009-11-11 |
2010-7-15 |
|
| Compositions for the in vivo delivery of rnai agents |
2009-6-05 |
2011-4-13 |
|
| miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
2008-12-19 |
2009-7-30 |
|
| miR-124 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
2008-12-01 |
2009-7-30 |
|
| miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR-331, … |
2008-7-03 |
2009-5-21 |
|
| miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
2008-6-06 |
2009-9-10 |
|
| miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
2008-5-22 |
2009-9-17 |
|
| miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
2008-5-22 |
2009-5-21 |
|
| miR-200 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
2008-5-21 |
2009-6-25 |
|
| miR-21 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
2008-5-14 |
2009-7-30 |
|
| miR-20 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
2008-4-30 |
2009-6-25 |
|
| Functions and targets of let-7 micro rnas |
2007-12-31 |
2009-6-25 |
|
| miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
2007-12-31 |
2009-7-09 |
|
| 障害の処置のための細菌 |
2023-6-06 |
2023-9-05 |
|
| Bactéria geneticamente modificada, composição farmaceuticamente aceitável … |
2016-3-02 |
2021-11-30 |
|